Black Global Network Black Global Network
    Advanced Search
  • Login
  • Register

  • Night mode
  • © 2025 Black Global Network
    About • Directory • Contact Us • Developers • Privacy Policy • Terms of Use • Refund • Sisters helping Sisters

    Select Language

  • Arabic
  • Bengali
  • Chinese
  • Croatian
  • Dutch
  • English
  • French
  • German
  • Hebrew
  • Hindi
  • Indonesian
  • Italian
  • Japanese
  • Persian
  • Portuguese
  • Russian
  • Spanish
  • Turkish
  • Urdu
Guest
NAN
News Feed
Chat rooms
Messages
Live
Blog
Events
More
  • Load more activities
Chat Rooms
    Twitter
    Tweets by @thebgnetwork
    Choose your favorites
    Black Global Network Chat
    Black Global Network Chat authentication app

    We give you This option to choose between Login as guest or with Black Global Network chat app

    ...

    View As EMBED

    ...

    Powred By FUSE Softwares
    kylie
    User Image
    Drag to reposition cover
    kylie

    kylie

    @kylie
    • Timeline
    • Likes
    • Following 0
    • Followers 24
    • Photos
    • Videos
    • Reels
    • Products
    0 Following
    24 Followers
    86 posts
    Female
    image
    kylie
    kylie
    2 yrs

    Digital Health market Size, Share, Trends by 2035

    The rise in the demand for convenient treatment options for patients across all age groups, specifically post COVID 19, has tremendously increased the adoption of digital therapeutics.

    This led to the integration of digital therapeutics solutions into routine healthcare and has helped in overcoming geographical barriers by enabling patients to access healthcare in quick, effective and cost-efficient manner. Several industry / non-industry players have shown a keen interest in digital therapeutics; with increasing adoption of such solutions, we expect the domain to present numerous lucrative investment opportunities.

    The financial opportunity within the digital therapeutics market has been analyzed across the following segments:
     Type of Solution
     Standalone Software Application
     Combination Offerings of Software Application + Device
     Combination Offerings of Software Application + AI Support
     Combination Offerings of Software Application + Personal Coach
     Combination Offerings of Software Application + Device + AI Support
     Combination Offerings of Software Application + Device + Personal Coach
     Others

     Type of Therapy
     Curative Solution
     Preventive Solution

     Therapeutic Area
     Cardiovascular Disorders
     Mental Health Problems
     Metabolic Disorders
     Neurological Disorders
     Pain Management
     Respiratory Disorders
     Sleep Disorders
     Substance Use Disorders
     Others

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific and Rest of the World

    The Investor Series: Opportunities in Digital Therapeutics Market, detailed profiles of the key public ventures engaged in the development of digital therapeutics solutions; each profile features a brief overview of the company, details on its management team, insights from its balance sheet (if available), details on its product / service portfolio, recent developments and key financial details (including company investment highlights, company fundamental and company technical analysis).

    Table of Contents

    Excel Deliverables
    1. Innovators and Product Dataset

    2. Funding and Investment Analysis

    3. Fundamental and Technical Financial Analysis

    4. Business Risk Analysis

    5. Market Forecast and Opportunity Analysis

    6. Return on Investment

    PowerPoint Deliverable
    1. Context

    2. Project Approach

    3. Project Objective

    4. Executive Summary

    Section I: Need for Digital Therapeutics and Innovators Landscape
    5. The Digital Health Market

    6. Digital Therapeutics: Innovator Landscape

    7. Digital Therapeutics: Product Landscape and Company Health Indexing

    8. Value Proposition Analysis

    9. Company Competitiveness Analysis

    Section II: Analysis of Investments
    10. Funding and Investment Analysis

    Section III: Financial Analysis and Assessment of Business Risks
    11. Financial Analysis of Public Ventures

    12. Company Profiles of Public Ventures

    13. Business Risk Analysis

    Section IV: Market Forecast and Opportunity Analysis
    14. Market Forecast

    Section V: Analysis of Returns on Investment and Key Acquisition Targets
    15. Analysis of Return on Investment

    16. Key Acquisition Targets

    17. Conclusion

    18. Appendices

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/....reports/opportunitie

    Learn from experts: do you know about these emerging industry trends?
    The Future of Dentistry: Dental 3D Printing
    Liposomes Development: Service Providers Landscape

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #digitaltherapeutic #digitaltherapeutics #digitaltherapeuticsmarket #marketresearch #marketinsights

    Like
    Comment
    Share
    avatar

    huggiebeauty

    As the vaping industry continues to evolve, a new trend has emerged: dummy vapes. https://relevantvapes.com/collections/kado-bar
    Like
    · Reply · 1726548072

    Delete Comment

    Are you sure that you want to delete this comment ?

    kylie
    kylie
    2 yrs

    Cell Cytometry market, Size and Share by 2035

    Novel cell cytometry platforms has emerged to be the crucial analytical and visualization tools with applications across various areas, such as immunology, molecular biology, cancer biology and infectious disease monitoring.

    As a result, developers are currently engaged in the development of technologically advanced cell cytometry platforms that offer better throughput and accuracy. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

     Type of Cytometer
     High Throughput Flow Cytometer
     Image Cytometer

     Company Size
     Very Small
     Small
     Mid-sized
     Large
     Very Large

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Rest of the World

    Key companies covered in the report
     Agilent
     Beckman Coulter Life Sciences
     Becton Dickinson
     Bio-Rad
     Chemotec
     Milkotronic
     Nexcelom Bioscinces
     Sartorius
     Sony Biotechnology
     Thermo Fischer Scientific
     Union Biometrica

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. High Throughput Flow Cytometers: Market Landscape

    5. Product Competitiveness Analysis: High Throughput Flow Cytometers

    6. Image Cytometers: Market Landscape

    7. Product Competitiveness Analysis: Image Cytometry

    8. Global Cell Cytometry: Company Profiles

    9. Global Cell Cytometry: Partnerships and Collaborations

    10. Recent Developments

    11. Patent Analysis

    12. Market Forecast

    13. Concluding Remarks

    14. Executive Insights

    15. Appendix 1: Tabulated Data

    16. Appendix 2: List of Companies and Organizations

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/....reports/cell-cytomet

    Learn from experts: do you know about these emerging industry trends?
    Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities
    Investment Opportunities in Women’s Digital Health

    Learn from our recently published whitepaper: -
    Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #flowcytometrycompanies #highthroughputflowcytometry #imagingflowcytometry #marketresearch #marketinsights

    Like
    Comment
    Share
    kylie
    kylie
    2 yrs

    Cell Free Expression market Analysis and Trends by 2023-2035

    Considering the benefits offered by cell free expression, including low cost of production, shortened production timelines and better control over the reaction environment, the adoption of cell free systems has increased over the years.

    Driven by the ongoing pace of innovation and growing adoption of cell free systems in the production of biomolecules, the global cell free expression market is anticipated to grow at a healthy pace in the foreseen future.

    The financial opportunity within the cell free market is analyzed across the following segments:

     Type of Cell Free System
     Crude Cell Lysate-based Systems
     Reconstituted Systems

     Type of Host Organism
     Microbial Cell Free Expression System
     Mammalian Cell Free Expression Systems
     Plant-based Cell Free Expression Systems
     Other Cell Free Expression Systems

     Type of Expression Method
     Coupled Transcription and Translation Method
     Translation Method

     End-User
     Pharmaceutical and Biotechnology Companies
     Academic and Research Institutes
     Other End-Users

     Key Geographical Regions
     North America
     Europe
     Asia Pacific
     Rest of the World

    The Cell Free Systems: Cell Free Expression Kits and Service Providers, 2023-2035 report features the following companies, which we identified to be key players in this domain:
     BioLinker
     biotechrabbit
     CellFree Sciences
     Creative Biolabs
     CUSABIO
     Daicel Arbor Biosciences
     LenioBio
     Promega
     Thermo Fisher Scientific
     Touchlight

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Market Landscape: Cell Free Expression Service Providers

    5. Market Landscape: Cell Free Expression Kits

    6. Cell Free Expression Service Providers: Company Competitiveness Analysis

    7. Cell Free Expression Kits: Product Competitiveness Analysis

    8. Company Profiles: Cell Free Expression Service Providers

    9. Company Profiles: Cell Free Expression Kit Providers

    10. Partnerships And Collaborations

    11. Funding And Investment Analysis

    12. Patent Analysis

    13. Market Forecast And Opportunity Analysis

    16. Appendix 1: Tabulated Data

    17. Appendix 2: List Of Companies And Organizations

    For additional details, please visit https://www.rootsanalysis.com/....reports/cell-free-ex

    Learn from experts: do you know about these emerging industry trends?
    Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities
    Investment Opportunities in Women’s Digital Health

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #cellfreebiomanufacturing #cellfreemanufacturing #cellfreeproteinsynthesis #marketresearch #marketinsights

    Like
    Comment
    Share
    kylie
    kylie
    2 yrs

    Non-Viral Transfection Reagents market, Size and Share by 2035

    Given the increasing focus on genetically modified therapies, there is a consequent rise in the demand for efficient gene delivery vectors; in recent years, innovators are actively evaluating the potential of non-viral transfection agents.
    Therefore, driven by the growing demand for cell and gene therapies, and the active ongoing efforts of industry stakeholders, the non-viral transfection reagents and systems market is anticipated to grow at a steady pace in the foreseen future.

    The future opportunity within the non-viral transfection reagents and systems market has been analyzed across the following segments:

     Non-Viral Based Transfection Methods
     Chemical-based Methods
     Physical-based Methods
     Other Methods

     End-Users
     Academic And Research Institutions
     Stem Pharmaceutical Companies
     Other End-Users

     Area of Application
     Clinical Applications
     Research Applications

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Rest of the World (RoW)

    The “Non-Viral Transfection Reagents and Systems Market (2nd Edition), 2023-2035” report features the following companies, which we identified to be key players in this domain:
     BEX
     Bio-Rad Laboratories
     BTX
     Celsion Corporation
     Genprex
     Inovio Pharmaceuticals
     MaxCyte
     MilliporeSigma
     NepaGene
     OZ Biosciences
     Thermo Fisher Scientific

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Non-Viral Transfection Reagents: Market Landscape

    5. Electroporation-Based Transfection Systems: Market Landscape

    6. Other Non-Viral Transfection Systems: Market Landscape

    7. Company Competitiveness Analysis

    8. Technology Competitiveness Analysis

    9. Company Profiles

    10. Potential Strategic Partners

    11. Big Pharma Initiatives

    12. Patent Analysis

    13. Publication Analysis

    14. Roots Analysis Pricing Strategy Framework

    15. Market Sizing and Opportunity Analysis

    16. Executive Insights

    17. Conclusion

    18. Appendix 1: Tabulated Data

    19. Appendix 2: List of Companies and Organizations

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/....reports/view_documen

    Learn from experts: do you know about these emerging industry trends?
    Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
    Digital Therapies: The “Digital Pills” of current generation

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #transfectionmethods #transfectionkits #nonviraltransfectionsystemsmarket #marketresearch #marketinsights

    Like
    Comment
    Share
    kylie
    kylie
    2 yrs

    DNA Encoded Library market Size, Share, Trends by 2035

    The DNA encoded library market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors. This can be attributed to the various benefits offered by these platforms, such as cost effectiveness, high diversity, minimal false positives, stability and rapid hit identification.

    The financial opportunity within the DNA encoded library market has been analyzed across the following segments:

     Application Area
     Hit Generation / Identification
     Hit to Lead
     Hit Validation / Optimization
     Other Application Areas

     Therapeutic Area
     Oncological Disorders
     Immunological Disorders
     Neurological Disorders
     Respiratory Disorders
     Dermatological Disorders
     Cardiovascular Disorders
     Infectious Diseases
     Other Therapeutic Areas

     End-user
     Pharma / Biopharma Industry
     Academic / Research Institute
     Other End-users

     Type of Payment Model Employed
     Upfront Payment
     Milestone Payment

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific

    The research also includes detailed profiles of key players (listed below) offering DNA encoded library platforms and services; each profile features a brief overview of the company, its financial information (if available), details on platform and service portfolio, recent developments and an informed future outlook.
     AlphaMa
     DICE Therapeutics
     DyNAbind
     HitGen
     NovAliX
     Vipergen
     WuXi AppTec
     X-Chem




    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Market Landscape

    5. Business Model Analysis

    6. Company Competitiveness Analysis

    7. Company Profiles

    8. Partnerships and Collaborations

    9. Global Event Analysis

    10. Patent Analysis

    11. Big Pharma Initiatives

    12. Case Study: Companies / Organizations Supporting the Development of DNA Encoded
    Libraries

    13. Market Forecast and Opportunity Analysis

    14. Concluding Remarks

    15. Executive Insights

    16. Appendix 1: Tabulated Data

    17. Appendix 2: List of Companies and Organizations

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/....reports/view_documen

    Learn from experts: do you know about these emerging industry trends?
    Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain
    CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

    Learn from our recently published whitepaper: -
    Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #dnaencodedlibrary #dnaencodedlibraries #dnaencodedchemicallibrary #marketresearch #marketinsights

    Like
    Comment
    Share
    Load more posts

    Unfriend

    Are you sure you want to unfriend?

    Report this User

    Edit Offer

    Add tier








    Select an image
    Delete your tier
    Are you sure you want to delete this tier?

    Reviews

    Pay By Wallet

    Payment Alert

    You are about to purchase the items, do you want to proceed?

    Request a Refund